Immune cells and cytolytic activity within the tumor microenvironment are being intensively studied. Through transcriptome profiling, immune cell enumeration using the xCell tool and cytolytic activity quantification according to granzyme A (GZMA) and perforin (PRF1) mRNA levels, we investigated immunoreactivity in tumor and/or tumor-free tongue tissue samples from 31 patients with squamous cell carcinoma of the oral tongue and 14 healthy individuals (control tongue tissues). We found significantly altered immune cell compositions (p < 0.001) and elevated cytolytic activity (p < 0.001) in tumor compared to tumor-free samples, and altered infiltration of a subset of immune cells (e.g. CD8+ T cells, p < 0.01) as well as increased cytolytic activity (p < 0.001) in tumor-free compared to control samples. Controlling for patient age at diagnosis and tumor stage, Cox regression analysis showed that high cytolytic activity in tumor-free samples associated with improved disease-free survival (hazard ratio= 4.20, 95% CI = 1.09-16.20, p = 0.037). However, the degree of cytolytic activity in tumor samples did not provide prognostic information. Taken together, our results show the presence of cancer-related immune responses in clinically tumor-free tongue in patients with squamous cell carcinoma of the oral tongue. Measuring cytolytic activity in tumor-free tongue samples contralateral to tumor might thus be an effective approach to predict clinical outcome.

Department of Clinical Sciences ENT Umeå University Umeå Sweden

Department of Medical Biosciences Pathology Umeå University Umeå Sweden

Institute of Molecular Genetics University Paris 7 St Louis Hospital Paris France

Regional Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic

Zobrazit více v PubMed

Binnewies M, Roberts EW, Kersten K, PubMed PMC

Baumeister SH, Freeman GJ, Dranoff G, PubMed

Hackl H, Charoentong P, Finotello F, PubMed

Charoentong P, Finotello F, Angelova M, PubMed

Thorsson V, Gibbs DL, Brown SD, PubMed PMC

Gentles AJ, Newman AM, Liu CL, PubMed PMC

Galon J, Mlecnik B, Bindea G, PubMed PMC

Pages F, Mlecnik B, Marliot F, PubMed

Finotello F, Trajanoski Z. Quantifying tumor‐infiltrating immune cells from transcriptomics data. Cancer Immunol Immunother 2018; 67: 1031–1040. PubMed PMC

Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 2017; 18: 220. PubMed PMC

Aran D, Camarda R, Odegaard J, PubMed PMC

Martinez‐Lostao L, Anel A, Pardo J. How do cytotoxic lymphocytes kill cancer cells? Clin Cancer Res 2015; 21: 5047–5056. PubMed

Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 2015; 15: 388–400. PubMed

Rooney MS, Shukla SA, Wu CJ, PubMed PMC

Bray F, Ferlay J, Soerjomataram I, PubMed

Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018; 18: 269–282. PubMed

Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol 2018; 52: 228–240. PubMed

Boldrup L, Coates PJ, Wahlgren M, PubMed PMC

Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517: 576–582. PubMed PMC

Boldrup L, Gu X, Coates PJ, PubMed PMC

Gu X, Boldrup L, Coates PJ, PubMed PMC

Lundqvist L, Stenlund H, Laurell G, PubMed

Sgaramella N, Coates PJ, Strindlund K, PubMed PMC

Wilms T, Khan G, Coates PJ, PubMed PMC

Shi W, Oshlack A, Smyth GK. Optimizing the noise versus bias trade‐off for Illumina whole genome expression BeadChips. Nucleic Acids Res 2010; 38: e204. PubMed PMC

Narayanan S, Kawaguchi T, Yan L, PubMed PMC

Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963–968. PubMed

Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9–22. PubMed

Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer 2018; 18: 19–32. PubMed

Lochhead P, Chan AT, Nishihara R, PubMed PMC

Dotto GP. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest 2014; 124: 1446–1453. PubMed PMC

Lohavanichbutr P, Houck J, Doody DR, PubMed PMC

Reis PP, Waldron L, Perez‐Ordonez B, PubMed PMC

Upregulation of Apoptosis Related Genes in Clinically Normal Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Effort to Maintain Tissue Homeostasis

Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck

Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival